Cargando…

Epidermal Fatty Acid-Binding Protein 5 (FABP5) Involvement in Alpha-Synuclein-Induced Mitochondrial Injury under Oxidative Stress

The accumulation of α-synuclein (αSyn) has been implicated as a causal factor in the pathogenesis of Parkinson’s disease (PD). There is growing evidence that supports mitochondrial dysfunction as a potential primary cause of dopaminergic neuronal death in PD. Here, we focused on reciprocal interacti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Yifei, Shinoda, Yasuharu, Cheng, An, Kawahata, Ichiro, Fukunaga, Kohji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7911662/ https://www.ncbi.nlm.nih.gov/pubmed/33499263 http://dx.doi.org/10.3390/biomedicines9020110

Ejemplares similares

Impact of Fatty Acid-Binding Proteins in α-Synuclein-Induced Mitochondrial Injury in Synucleinopathy
por: Cheng, An, et al.
Publicado: (2021)

An α-synuclein decoy peptide prevents cytotoxic α-synuclein aggregation caused by fatty acid binding protein 3
por: Fukui, Naoya, et al.
Publicado: (2021)

Fatty acid-binding proteins 3 and 5 are involved in the initiation of mitochondrial damage in ischemic neurons
por: Guo, Qingyun, et al.
Publicado: (2022)

Fatty Acid Binding Protein 5 Mediates Cell Death by Psychosine Exposure through Mitochondrial Macropores Formation in Oligodendrocytes
por: Cheng, An, et al.
Publicado: (2020)

Fatty Acid-Binding Protein 3 is Critical for α-Synuclein Uptake and MPP(+)-Induced Mitochondrial Dysfunction in Cultured Dopaminergic Neurons
por: Kawahata, Ichiro, et al.
Publicado: (2019)

Anti-Epileptic Effects of FABP3 Ligand MF1 through the Benzodiazepine Recognition Site of the GABA(A) Receptor
por: Yabuki, Yasushi, et al.
Publicado: (2020)

A novel fatty acid-binding protein 5 and 7 inhibitor ameliorates oligodendrocyte injury in multiple sclerosis mouse models
por: Cheng, An, et al.
Publicado: (2021)

Fatty Acid Binding Protein 3 Enhances the Spreading and Toxicity of α-Synuclein in Mouse Brain
por: Yabuki, Yasushi, et al.
Publicado: (2020)

Amelioration of Nicotine-Induced Conditioned Place Preference Behaviors in Mice by an FABP3 Inhibitor
por: Jia, Wenbin, et al.
Publicado: (2023)

Pathogenic Impact of α-Synuclein Phosphorylation and Its Kinases in α-Synucleinopathies
por: Kawahata, Ichiro, et al.
Publicado: (2022)

SAK3 Administration Improves Spine Abnormalities and Cognitive Deficits in App(NL-G-F/NL-G-F) Knock-in Mice by Increasing Proteasome Activity through CaMKII/Rpt6 Signaling
por: Izumi, Hisanao, et al.
Publicado: (2020)

Fatty Acid-Binding Proteins: Their Roles in Ischemic Stroke and Potential as Drug Targets
por: Guo, Qingyun, et al.
Publicado: (2022)

α‐Synuclein decoy peptide protects mice against α‐synuclein‐induced memory loss
por: Guo, Qingyun, et al.
Publicado: (2023)

Using Fatty Acid-Binding Proteins as Potential Biomarkers to Discriminate between Parkinson’s Disease and Dementia with Lewy Bodies: Exploration of a Novel Technique
por: Kawahata, Ichiro, et al.
Publicado: (2023)

Fatty Acid-Binding Proteins Aggravate Cerebral Ischemia-Reperfusion Injury in Mice
por: Guo, Qingyun, et al.
Publicado: (2021)

Serum fatty acid binding protein 5 (FABP5) as a potential biomarker of inflammation in psoriasis
por: Kozłowska, Dorota, et al.
Publicado: (2021)

Cigarette smoke inhibits LPS-induced FABP5 expression by preventing c-Jun binding to the FABP5 promoter
por: Rao, Deviyani, et al.
Publicado: (2017)

Degradation of Tyrosine Hydroxylase by the Ubiquitin-Proteasome System in the Pathogenesis of Parkinson’s Disease and Dopa-Responsive Dystonia
por: Kawahata, Ichiro, et al.
Publicado: (2020)

Protein Kinases and Neurodegenerative Diseases
por: Kawahata, Ichiro, et al.
Publicado: (2023)

A Critical Role of Fatty Acid Binding Protein 4 and 5 (FABP4/5) in the Systemic Response to Fasting
por: Syamsunarno, Mas Rizky A. A., et al.
Publicado: (2013)

Fatty Acid Binding Protein 5 (FABP5) Promotes Aggressiveness of Gastric Cancer Through Modulation of Tumor Immunity
por: Qiu, Mei-qing, et al.
Publicado: (2023)

Effect of methotrexate treatment on the expression of epidermal-fatty acid-binding protein (E-FABP) and apolipoproteins in patients with psoriasis
por: Owczarczyk-Saczonek, Agnieszka, et al.
Publicado: (2020)

Level of Fatty Acid Binding Protein 5 (FABP5) Is Increased in Sputum of Allergic Asthmatics and Links to Airway Remodeling and Inflammation
por: Suojalehto, Hille, et al.
Publicado: (2015)

Salivary and Lacrimal Gland Alterations of the Epidermal Fatty Acid-Binding Protein (E-FABP) in Non-Obese Diabetic Mice †
por: Dogru, Murat, et al.
Publicado: (2022)

The fatty acid binding protein 7 (FABP7) is involved in proliferation and invasion of melanoma cells
por: Slipicevic, Ana, et al.
Publicado: (2008)

Dopamine D2 Long Receptors Are Critical for Caveolae-Mediated α-Synuclein Uptake in Cultured Dopaminergic Neurons
por: Kawahata, Ichiro, et al.
Publicado: (2021)

Independent and Distinct Associations of FABP4 and FABP5 With Metabolic Parameters in Type 2 Diabetes Mellitus
por: Furuhashi, Masato, et al.
Publicado: (2020)

The covalent reactivity of functionalized 5-hydroxy-butyrolactams is the basis for targeting of fatty acid binding protein 5 (FABP5) by the neurotrophic agent MT-21
por: Svenningsen, Esben B., et al.
Publicado: (2022)

The Role of CaMKII and ERK Signaling in Addiction
por: Jia, Wenbin, et al.
Publicado: (2021)

Epidermal Fatty Acid Binding Protein (E-FABP) Is Not Required for the Generation or Maintenance of Effector and Memory T Cells following Infection with Listeria monocytogenes
por: Li, Bing, et al.
Publicado: (2016)

PS05. Amelioration of PTSD-like Behavior by Melatonin in FABP3 Null Mice
por: Fukunaga, Kohji, et al.
Publicado: (2016)

T-Type Ca(2+) Enhancer SAK3 Activates CaMKII and Proteasome Activities in Lewy Body Dementia Mice Model
por: Xu, Jing, et al.
Publicado: (2021)

Fatty Acid Binding Proteins FABP9 and FABP10 Participate in Antibacterial Responses in Chinese Mitten Crab, Eriocheir sinensis
por: Cheng, Lin, et al.
Publicado: (2013)

PT562. Alzheimer disease therapeutics candidate, SAK3 improves the cognitive functions through inhibition of amyloid beta accumulation in APP23 mice.
por: Izumi, ○Hisanao, et al.
Publicado: (2016)

Expression and enhancement of FABP4 in septoclasts of the growth plate in FABP5-deficient mouse tibiae
por: Bando, Yasuhiko, et al.
Publicado: (2021)

Fatty acid-binding protein 5 (FABP5)-related signal transduction pathway in castration-resistant prostate cancer cells: a potential therapeutic target
por: Naeem, Abdulghani A, et al.
Publicado: (2019)

FABP5 promotes lymph node metastasis in cervical cancer by reprogramming fatty acid metabolism
por: Zhang, Chunyu, et al.
Publicado: (2020)

P2X7 Receptor is Involved in Mitochondrial Dysfunction Induced by Extracellular Alpha Synuclein in Neuroblastoma SH-SY5Y Cells
por: Wilkaniec, Anna, et al.
Publicado: (2020)

Transcriptome and Metabolome Analyses in Exogenous FABP4- and FABP5-Treated Adipose-Derived Stem Cells
por: Yamamoto, Tokunori, et al.
Publicado: (2016)

FABP4 reversed the regulation of leptin on mitochondrial fatty acid oxidation in mice adipocytes
por: Gan, Lu, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_i12c0mf6j58ruvrk9h2ef8vqs0